Posted on 9/20/20
Melina Sánchez Montañés, Impact First Investments, Interview with Irad Eichler, CEO at 7Chairs
Irad Eichler is a social entrepreneur who co-founded 7Chairs in 2019. 7Chairs is a teletherapy startup focused on providing emotional support to everyone who is dealing with . . .
Posted on 9/17/20
CorMedix Appoints Paulo Costa to Board
CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products
Posted on 9/17/20
Cue Biopharma Appoints Tamar Howson To Board
Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted
Posted on 9/17/20
Aravive Appoints Michael W. Rogers to Board
Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing transformative therapeutics, today announced that Michael W. Rogers joined the Company’s Board of Directors.
Posted on 9/17/20
Owens Corning Elects Alfred Festa Former Chairman of W. R. Grace To Board
Owens Corning (NYSE:OC) announced today that Alfred (Fred) E. Festa, former Chairman of W.R. Grace & Co., has been elected to the company’s Board of Directors.
Posted on 9/16/20
Dentsply Sirona Appoints Clyde Hosein as Board Member
CHARLOTTE, N.C., Sept. 16, 2020 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that Clyde R. Hosein has . . .
Posted on 9/16/20
AVCT Appoints Xavier Williams as CEO
ATLANTA, Sept. 16, 2020 (GLOBE NEWSWIRE) -- American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT), a leading cloud communications and IT services provider, is pleased to announce . . .
Posted on 9/16/20
Geltor Appoints Doug Cameron to Board of Directors
Biodesign company Geltor, Inc. today announced the addition of storied biotechnology pioneer Dr. Douglas (Doug) Cameron to its Board of Directors.An industry trailblazer bringing over 30 . . .
Posted on 9/16/20
vTv Therapeutics Adds MacAndrews & Forbes EVP to Board
vTv Therapeutics, a clinical-stage biopharmaceutical company, added Edward P. Taibi to its board, the company announced in a press release on Tuesday.Taibi has spent the last . . .
Posted on 9/16/20
Hilary Gilliam Thompson Appoints James A. "Sandy" Winnefeld to Federal Advisory Board
SpiderOak Mission Systems, provider of cryptographically-secure communication and collaboration products, is pleased to announce that Admiral James A. "Sandy" Winnefeld
Posted on 9/16/20
INVO Bioscience Appoints Barbara Ryan and Matthew Szot to Board
INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only . . .
Posted on 9/16/20
Abacode Appoints Cindy Schwarzkopf to Board
Abacode, one of the fastest growing Cybersecurity and Compliance firms in the United States, announced today that Cynthia "Cindy" Schwarzkopf has joined their Board of Advisors.
Posted on 9/16/20
Imvax Appoints Wendy DiCicco to Board
Imvax, Inc., an emerging oncology leader that is revolutionizing immunotherapy for patients with malignant glioblastomas (GBM) and other solid tumors with significant unmet medical needs, today . . .
Posted on 9/16/20
DarioHealth Appoints Eric Milledge as Chairman
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company's newly-established . . .
Posted on 9/16/20
Revitope Oncology Appoints Carsten Reinhardt, M.D., Ph.D., to Board
Revitope Oncology, Inc., a biotechnology company advancing a new class of precision cancer immunotherapies today announced the appointment of life sciences industry veteran Carsten Reinhardt, M.D., . . .
Posted on 9/16/20
Advisor360 Appoints William D. Green to Board
Advisor360°, provider of a unified, integrated software suite for advisors, clients, and Broker-Dealers/Rollup-RIAs today announced that seasoned enterprise IT industry veteran William (Bill) D. Green has . . .
Posted on 9/16/20
Newly Appoints Vivian Kelly and Lars Voedisch to Board
GlobalCom PR Network (GCPR), an alliance of 80 public relations agencies in more than 100 countries, is delivering even greater strategic value to companies looking to . . .
Posted on 9/16/20
MVB Financial Corp. Appoints Anna Sainsbury to Board
The Board of Directors of MVB Financial Corp.(Nasdaq: MVBF) has announced the appointment of Anna Sainsbury as a Member of the Board.
Posted on 9/16/20
DXC Technology Appoints Paul Saleh as CEO
DXC Technology (NYSE: DXC) today announced that DXC Chief Financial Officer, Paul Saleh, has been named Chief Executive Officer of DXC’s U.S. State and Local Health . . .
Posted on 9/16/20
Advanced Dermatology and Cosmetic Surgery Appoints Brian T. Griffin as Chief Executive Officer
MAITLAND, Fla.--(BUSINESS WIRE)--Advanced Dermatology and Cosmetic Surgery (ADCS), a national leader in dermatology care, today announced that Brian T. Griffin has been appointed as Chief Executive . . .
Posted on 9/16/20
Volastra Therapeutics Appoints Charles Hugh-Jones as Chief Executive Officer
Volastra Therapeutics, a biotechnology company developing novel therapies to treat and prevent the formation of metastatic disease, has named Charles Hugh-Jones, MD, FRCP, as its Chief . . .
Posted on 9/16/20
Rubicon Appoints Elizabeth Montoya to Board
Rubicon, a software company that provides smart waste and recycling solutions to businesses and governments worldwide, announced today that Elizabeth Montoya
Posted on 9/16/20
Immunome Announces Creation of COVID-19 Advisory Board
EXTON, Pa.--(BUSINESS WIRE)--Immunome, a biotechnology company harnessing the human B cell response to develop potentially first-in-class investigational therapeutics for oncology and infectious diseases, announced today the . . .
Posted on 9/16/20
Acceleron Appoints Laura J. Hamill to Board
Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta superfamily therapeutics
Posted on 9/16/20
Voyager Therapeutics Appoints Nancy Vitale to Board
Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases

